![]()
|
|
||||||||
(Received for publication, September 26, 1996, and in revised form, January 20, 1997)
From Annexin V belongs to a family of proteins that
interact with phospholipids in a
Ca2+-dependent manner. This protein has
been demonstrated to have anti-phospholipase A2 activity.
However, this effect has never yet been reported with the 85-kDa
cytosolic PLA2 (cPLA2). We studied, in a model
of differentiated and streptolysin O-permeabilized HL-60 cells, the
effect of annexin V on cPLA2 activity after stimulation by
calcium, GTP
Volume 272, Number 16,
Issue of April 18, 1997
pp. 10474-10482
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
EVIDENCE OF CRUCIAL IMPORTANCE OF DOMAIN I TYPE II
Ca2+-BINDING SITE IN THE MECHANISM OF
INHIBITION
§
,
,
,
,
and
Unité 332, Institut Cochin de
Génétique Moleculaire, INSERM, 22 rue Mechain, 75014 Paris,
France and the § Medical Intensive Care Unit, Cochin
University Hospital, 75014 Paris, France
S (guanosine 5
-O-(3-thiotriphosphate)),
formyl-Met-Leu-Phe, or phorbol 12-myristate 13-acetate. Both
recombinant and human placental purified annexin V inhibit
cPLA2 activity whatever the stimulus used. The decrease of
arachidonic acid release is of 40 and 50%, respectively, at
[Ca2+] of 3 and 10 µM. The mechanism of
inhibition was also analyzed. cPLA2 requires calcium and
protein kinase C (PKC) or mitogen-activated protein kinase
phosphorylation for its activation. As annexin V was shown to be an
endogenous inhibitor of PKC, PKC-stimulated cPLA2 activity
was analyzed. Using GF109203x, a specific PKC inhibitor, we
demonstrated that this pathway is of minor importance in our model.
cPLA2 inhibition by annexin V is not linked to PKC
inhibition. To test the hypothesis of phospholipid depletion, mutants
of annexin V were constructed using mutagenesis directed to
Ca2+ site. We demonstrate that the Ca2+ site
located in domain I is necessary for the inhibitory effect of annexin V
on cPLA2 activity. The site in domain IV is also involved
but with less efficiency. In contrast, mutations in site II and III do
not modify this effect. Moreover, annexin V mutated on all sites does
not inhibit cPLA2. Thus, we propose a predominant role of
module (I/IV) in the biological action of annexin V, which, in
physiological conditions, may control cPLA2 activity by
depletion of the phospholipid substrate.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Watanabe, S. Kondo, K. Mizuno, W. Yano, H. Nakao, Y. Hattori, K. Kimura, and T. Nishida Promotion of Corneal Epithelial Wound Healing In Vitro and In Vivo by Annexin A5 Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1862 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuwata, T. Nonaka, M. Murakami, and I. Kudo Search of Factors That Intermediate Cytokine-induced Group IIA Phospholipase A2 Expression through the Cytosolic Phospholipase A2- and 12/15-Lipoxygenase-dependent Pathway J. Biol. Chem., July 8, 2005; 280(27): 25830 - 25839. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Camors, V. Monceau, and D. Charlemagne Annexins and Ca2+ handling in the heart Cardiovasc Res, March 1, 2005; 65(4): 793 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kenis, H. van Genderen, A. Bennaghmouch, H. A. Rinia, P. Frederik, J. Narula, L. Hofstra, and C. P. M. Reutelingsperger Cell Surface-expressed Phosphatidylserine and Annexin A5 Open a Novel Portal of Cell Entry J. Biol. Chem., December 10, 2004; 279(50): 52623 - 52629. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Monceau, Y. Belikova, G. Kratassiouk, D. Charue, E. Camors, C. Communal, P. Trouve, F. Russo-Marie, and D. Charlemagne Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes Cardiovasc Res, December 1, 2004; 64(3): 496 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Riquelme, P. Llanos, E. Tischner, J. Neil, and B. Campos Annexin 6 Modulates the Maxi-chloride Channel of the Apical Membrane of Syncytiotrophoblast Isolated from Human Placenta J. Biol. Chem., November 26, 2004; 279(48): 50601 - 50608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jin, C. Smith, H.-Y. Hsieh, D. F. Gibson, and J. F. Tait Essential Role of B-helix Calcium Binding Sites in Annexin V-Membrane Binding J. Biol. Chem., September 24, 2004; 279(39): 40351 - 40357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Farber, R. A. De Rose, E. S. Olson, and M. E. Halpern The Zebrafish Annexin Gene Family Genome Res., June 1, 2003; 13(6): 1082 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Montaville, J.-M. Neumann, F. Russo-Marie, F. Ochsenbein, and A. Sanson A New Consensus Sequence for Phosphatidylserine Recognition by Annexins J. Biol. Chem., June 28, 2002; 277(27): 24684 - 24693. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. van den Eijnde, M. J. B. van den Hoff, C. P. M. Reutelingsperger, W. L. van Heerde, M. E. R. Henfling, C. Vermeij-Keers, B. Schutte, M. Borgers, and F. C. S. Ramaekers Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation J. Cell Sci., March 12, 2002; 114(20): 3631 - 3642. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Di Simone, R. Castellani, D. Caliandro, and A. Caruso Monoclonal Anti-Annexin V Antibody Inhibits Trophoblast Gonadotropin Secretion and Induces Syncytiotrophoblast Apoptosis Biol Reprod, December 1, 2001; 65(6): 1766 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. MIELE Antiflammins: Bioactive Peptides Derived from Uteroglobin Ann. N.Y. Acad. Sci., December 1, 2000; 923(1): 128 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Solito, I. A. Romero, S. Marullo, F. Russo-Marie, and B. B. Weksler Annexin 1 Binds to U937 Monocytic Cells and Inhibits Their Adhesion to Microvascular Endothelium: Involvement of the {alpha}4{beta}1 Integrin J. Immunol., August 1, 2000; 165(3): 1573 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marshall, E. Krump, T. Lindsay, G. Downey, D. A. Ford, P. Zhu, P. Walker, and B. Rubin Involvement of Cytosolic Phospholipase A2 and Secretory Phospholipase A2 in Arachidonic Acid Release from Human Neutrophils J. Immunol., February 15, 2000; 164(4): 2084 - 2091. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kurosawa, K. Goi, T. Inukai, T. Inaba, K.-S. Chang, T. Shinjyo, K. M. Rakestraw, C. W. Naeve, and A. T. Look Two Candidate Downstream Target Genes for E2A-HLF Blood, January 1, 1999; 93(1): 321 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. K. Lim, E. Solito, F. Russo-Marie, R. J. Flower, and M. Perretti Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: Effect of lipocortin 1 PNAS, November 24, 1998; 95(24): 14535 - 14539. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. O'Brien, D. L. Piddington, C. Voelkel-Johnson, D. J. Richards, L. A. Hadley, and S. M. Laster Sustained Phosphorylation of Cytosolic Phospholipase A2 Accompanies Cycloheximide- and Adenovirus-Induced Susceptibility to TNF J. Immunol., August 1, 1998; 161(3): 1525 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Kim, H. J. Rhee, J. Ko, Y. J. Kim, H. G. Kim, J. M. Yang, E. C. Choi, and D. S. Na Inhibition of Cytosolic Phospholipase A2 by Annexin I. SPECIFIC INTERACTION MODEL AND MAPPING OF THE INTERACTION SITE J. Biol. Chem., May 4, 2001; 276(19): 15712 - 15719. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, M. A. Kaetzel, S. E. Yoo, P. S. Kim, and J. R. Dedman Ligand-regulated secretion of recombinant annexin V from cultured thyroid epithelial cells Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1313 - C1321. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |